Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET
-
Redwood AI closes $3.5M private placement with U.S. investor
-
Redwood AI Announces Closing of $3.5 Million Private Placement
-
Maxim Group Starts Airsculpt Technologies Inc. (AIRS) at Buy
-
Maxim Group Starts American Bitcoin Corp (ABTC) at Buy
-
Maxim Group Starts Duke Robotics (DUKR) at Buy
-
B2i Digital Announces Precious Metals and Critical Minerals Conference
-
Maxim Group Upgrades Akari Therapeutics (AKTX) to Buy
-
Maxim Group Starts Rein Therapeutics (RNTX) at Buy
-
Herbalife CFO to Participate in Maxim Group “Health, Wellness & Longevity” Virtual Conference on July 22
-
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
-
Boxabl completes SPAC merger, begins trading on Nasdaq at $3.5B value
-
BOXABL Inc. (NASDAQ: BXBL) Completes Business Combination with FG Merger II Corp. at $3.5 Billion Valuation
-
Redwood AI prices $3.5M private placement with U.S. investor
-
Redwood AI Announces Pricing of $3.5 Million Private Placement
-
Maxim Group Downgrades AtaiBeckley Inc (ATAI) to Hold
-
Electrified Materials closes $9.5M Series A preferred stock offering
-
American Resources' Electrified Materials Announces Closing of its Previously Announced Private Placement for Gross Proceeds of $9.5 Million
-
InvestorNewsBreaks – Nuvectis Pharma, Inc. (NASDAQ: NVCT) Prices $100 Million Public Offering
-
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
-
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
-
Vitalist to Participate in a Fireside Chat at the Health, Wellness & Longevity Conference Presented by Maxim Group
-
Maxim Group Starts Heartbeam Inc. (BEAT) at Buy
-
Autonomix Medical raises $2.6M via warrant inducement agreement
-
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
-
Elong Power closes $6.6M public offering on Nasdaq
-
Elong Power Holding Limited Announces Closing of US$6.6 Million Public Offering
-
SuperCom prices $7.5 million registered direct offering at $10.25
-
SuperCom Announces Pricing of $7.5 Million Registered Direct Offering
-
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
-
Elong Power prices $6.6M public offering at $0.40 per unit
-
Elong Power Holding Limited Announces Pricing of US$6.6 Million Public Offering
-
Barfresh to Participate in the Health, Wellness & Longevity Virtual Conference Hosted by Maxim Group LLC on Wednesday, July 22nd
-
Aethlon Medical prices $4M follow-on stock offering at $0.71 per share
-
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
-
Lucas GC cancels ATM offering and proposed public share sale
-
Lucas GC Limited Provides Updates on Its Financing Plans
-
Maxim Group Starts Amass brands (AMSS) at Buy
-
AB Science announces the successful completion of a EUR 2.3 million private placement
-
Maxim Group Starts Allied Irish Banks (AIB) at Buy
-
Biodexa prices $3.5M offering of shares, warrants, and warrant inducement
-
MediciNova completes last patient visit in NAFLD Phase 2 trial
-
Biodexa prices $3.5M offering of shares, warrants, and pre-funded warrants
-
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants
-
MediciNova CEO Provides Shareholder Update
-
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants
-
Nuvectis Pharma prices $100M public offering at $20 per share
-
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
-
Eco Wave Power raises $4M in direct offering priced at premium
-
Eco Wave Power Announces Closing of $4.0 Million Strategic Financing Priced at a Premium to Market to Advance Global Project Deployment and AI-Driven Technology


